Introduction {#sec1}
============

The total number of overweight and obese people in the world reached 2.1 billion in 2013; the United States tops the list of the 671 million obese people in the world.[@bib1] Although the trend in average body mass index (BMI) has flattened out recently in high-income regions, it has accelerated in east and South Asia.[@bib2] Obesity is a worldwide public problem, often associated with diabetes, cardiovascular disease, depression, sleep apnea syndrome, and other chronic diseases.[@bib3] It severely affects the quality of life of patients and is associated with increased morbidity and mortality from a variety of chronic diseases.[@bib3], [@bib4] Male sexual dysfunction is also common. Men's inability to have satisfactory sex can cause a range of psychological problems, including depression, anxiety, poor body image, and low self-esteem.[@bib5]

Erectile dysfunction is widely found in obese people, with 79% of patients with erectile dysfunction belonging to the overweight group.[@bib6] Abdominal obesity can increase the risk of erectile dysfunction by 50%,[@bib7] and the lack of confidence caused by obesity may also promote the occurrence of erectile dysfunction.[@bib8] At present, more and more attention has been paid to obesity-related sexual dysfunction. According to existing studies, mechanisms responsible for the independent influence of obesity on the erectile dysfunction may be hormonal imbalance, endothelial dysfunction, insulin resistance, psychological factors, and physical inactivity.[@bib8], [@bib9] Low testosterone levels associated with obesity may lead to low sexual desire, whereas high reactive oxygen species production and the decrease in antioxidant capacity in obese patients will lead to endothelial dysfunction that can cause organic erectile dysfunction.[@bib10], [@bib11] In addition to obesity itself, obesity-related comorbidities, such as diabetes, coronary heart disease, hypertension, and depression, are risk factors for male sexual dysfunction.[@bib8]

Bariatric surgery has been widely used to treat morbidly obese patients and their associated complications, such as type 2 diabetes and sleep apnea syndrome,[@bib12], [@bib13] as well as improve cardiovascular and renal functions.[@bib14], [@bib15] Recent studies have shown that bariatric surgery for morbidly obese patients cannot only significantly reduce weight in a short period of time, but also significantly improve sexual function.[@bib16], [@bib17], [@bib18], [@bib19] However, because the number of studies and the sample size are still small, and most of them are cohort studies, the effect of weight loss surgery on various domains of male sexual function is still controversial. In order to more accurately assess the relationship between bariatric surgery and male sexual function, we conducted a comprehensive systematic evaluation and meta-analysis of the existing studies in order to provide a basis for clinical decisions.

Materials and methods {#sec2}
=====================

Search Strategy {#sec2.1}
---------------

A systematic research was carried out in Medline via PubMed, EMBASE, Cochrane Library, and Web of Science up to March 16, 2019. The search terms used included bariatric surgery OR gastric bypass OR sleeve gastrectomy OR gastric banding OR gastroplasty OR jejunoileal bypass and erectile OR sexual. We also conducted a search of published research literature and a manual search of grey literature to ensure that no relevant articles were omitted. This system review and meta-analysis are reported in accordance with the preferred reporting items of the system review and meta-analysis (PRISMA).[@bib20]

Inclusion and Exclusion Criteria {#sec2.2}
--------------------------------

Inclusion criteria were as follows: (a) the study type was randomized controlled trial or observational study; (b) male obese patients who underwent weight-loss surgery were studied regardless of race, age, or course of disease; (c) the selected intervention was bariatric surgery, regardless of whether it was restrictive, malabsorptive, or mixed; (d) studies that compared patients before and after surgery or compared with control groups or patients underwent other interventions; and (e) outcomes were evaluated erectile function using International Index of Erectile Function (IIEF) score and Five-Item IIEF.

Exclusion criteria were as follows: (a) did not separate women and men; (b) did not define obesity; (c) did not use bariatric surgery as intervention; (d) outcomes are unclear and data are missing; and (e) republished literature.

Selection Process and Data Abstraction {#sec2.3}
--------------------------------------

Two reviewers reviewed the titles, abstracts, and full text independently according to inclusion and exclusion criteria. Disputes arising during the title and abstract screening phase are directly incorporated into the full text assessment to ensure that all relevant papers are not omitted. In the full text stage, the differences are resolved by negotiation between two reviewers. If there is no agreement, a third reviewer is consulted.

The two reviewers independently extracted relevant data with the predesigned data extraction table. Baseline data extracted included: first author and publication time, country, number of cases, type of study, age, BMI, outcome measures, operation method, comparison, follow-up time, and quality score.

Outcomes Assessed and Risk of Bias Assessment {#sec2.4}
---------------------------------------------

The included study should include at least one specific change of outcome index before and after surgery. The primary outcomes of our study include IIEF and its 5 domains (IIEF-Erectile Function; IIEF-Desire; IIEF-Orgasm Function; IIEF-Intercourse Satisfaction; and IIEF-Total Satisfaction) and Five-Item IIEF.[@bib21], [@bib22] Although IIEF and Five-Item IIEF have similar functions, there are still differences in significance and scoring methods, therefore, we conducted meta-analysis on them separately to avoid bias. In order to more accurately understand the effect of surgery on each domain of IIEF, we conducted meta-analysis on the 5 domains of IIEF. The secondary outcomes include BMI, total testosterone, and free testosterone. The nonrandom study methodology index (MINORS) tool[@bib23] was used to assess the risk of bias in individual studies, with the Jadad Score[@bib24] and Agency for Healthcare Research and Quality Score[@bib25] also being used to assess the quality of 1 randomized clinical trial (RCT) and one cross-sectional study, respectively.

Statistical Analysis {#sec2.5}
--------------------

All statistical analyses and meta-analyses were performed using Cochrane Review Manager 5.3 (China), and the significance level was set at *P* \< 0.05. All results were continuous in nature. The effect size was estimated by calculating the mean difference (MD) of the results and their 95% CIs, and the combined effect was estimated. Heterogeneity was assessed using inconsistency (I^2^) statistics. We believe that if I^2^ is \>50%, it represents considerable heterogeneity, and the random-effect model is used; if I^2^ is \<50%, it represents heterogeneity within the acceptable range, and the fixed effect model is used. For studies that only reported the range of median and quartile, the estimation method proposed by Wan et al[@bib26] was used to estimate the mean and SD.

Sensitivity Analysis and Publication Bias {#sec2.6}
-----------------------------------------

Sensitivity analysis was performed to identify the source of heterogeneity. The heterogeneity and pooled effect values after the removal of a single study were recalculated and recorded by eliminating each literature article one by one. We used Revman 5.3 to analyze the changes in I^2^ and Stata software to obtain the forest plots after each study was successively removed. After discovering the source of heterogeneity, the experiment design, sample size, evaluation criteria, and other aspects were analyzed to find out the reason why it became the source of heterogeneity.

We quantified publication bias by the egger method. When the *P* value obtained by the egger method was \>0.05, it indicated that there was no significant publication bias; on the contrary, it indicated the existence of publication bias. If publication bias exists, we will test the influence of publication bias on the results by the rim and fill method. If it is found that publication bias has obvious influence on the results, we will discuss it in detail in the Discussion section.

Results {#sec3}
=======

Literature Retrieval Results and Basic Characteristics {#sec3.1}
------------------------------------------------------

We have searched a large number of documents, carefully studied, and screened them, and the detailed process is shown in [Figure 1](#fig1){ref-type="fig"}. The results showed a total of 1,065 relevant studies chiefly from electronic databases. After removing duplicates, 642 references were excluded according to title and abstract because they were reviews or letters or irrelevant to the subject of this study. By reading the full text of 32 cations, 12 studies were eventually included,[@bib16], [@bib17], [@bib18], [@bib19], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34] including 420 participants. Among these studies, 3 were from Brazil, 6 from European countries, 2 from the United States, and 1 from China. Of the 12 studies, one was an RCT,[@bib28] 1 was cross-sectional,[@bib17] and the rest were prospective cohort studies that were self-controlled. The included studies ranged from 2009 to 2017, with a median follow-up of 12 months (a range of 1 to 36 months). For studies reporting multiple time points, we selected the points closest to 12 months for analysis. In our meta-analysis, the main characteristics and data of each study are shown in [Table 1](#tbl1){ref-type="table"}.Figure 1Literature search and selection process.Table 1The main characteristics and data of each studyStudyCountryCaseStudy typeAgeBMI (kg/m^2^)OutcomeOperation methodComparisonFollow-up (mo)Quality scoreAraújo et al[@bib27]Brazil21PC20−5040BCDEFGRYGBBefore vs after1214Reis et al[@bib28]Brazil10/10RCT36.7 ± 11.5/42.2 ± 11.055.7 ± 7.8/54.0 ± 6.1AHIJRYGBBefore vs after and between groups (MT NIP)243/5Ranasinghe et al[@bib29]UK34PC52.8 ± 9.3347.3 ± 12.67ABLGBBefore vs after812Mora et al[@bib30]Spain39PC18−6546.90 ± 7.77ABCDEFGIJRYGB/LSGBefore vs after1212Sarwer et al[@bib31]USA27/20PC40−5645.9 (3.0−94.3)CDEFGRYGBBetween groups (LM)CS13Layus et al[@bib33]Brazil14/14PCCS44.9 ± 7.2BHRYGBBefore vs after612Sarwer et al[@bib16]USA32PC24−6445.1 (42.0−52.2)CDEFGIJRYGBBefore vs after3613Efthymiou et al[@bib34]Greece30PC37.30 ± 9.6050.66 ± 7.90CDEFGSG/RYGB/BPD+RYBefore vs after1214Kun et al[@bib32]China39RC45.20 ± 12.3041.20 ± 8.50AHIRYGBBefore vs after1213Janik et al[@bib17]Poland30/31CS[∗](#tbl1fnlowast){ref-type="table-fn"}29 ± 243 ± 10ABCDEFGLSG/RYGBBetween groups12--189/11Groutz et al[@bib18]Israel39PC40.70 ± 12.4042.80 ± 5.60ACDEFGLSGBefore vs after314Aleid et al[@bib19]UK30PC47.2 ± 8.1\>35ABLSG/LGBBefore vs after1−612[^1][^2][^3]

Methodological Quality Assessment {#sec3.2}
---------------------------------

The MINORS scale evaluation shows that 10 prospective cohort studies are of high grade and good quality. We used Jadad and Agency for Healthcare Research and Quality scales to evaluate Reis et al[@bib28] and Janik et al,[@bib17] respectively, and found that both of them had relatively high quality. Specific methodological quality evaluation results are shown in [Table 2](#tbl2){ref-type="table"}.Table 2Quality assessment of included studiesStudyMINORS criteriaA clearly stated aimInclusion of consecutive patientsProspective collection of dataEnd points appropriate to the aims of the studyUnbiased assessment of the study end pointFollow-up period appropriate to the aim of the studyLoss to follow-up \<5%Prospective calculation of the study sizeTotalAraújo et al[@bib27]2222222014Ranasinghe et al[@bib29]2222220012Mora et al[@bib30]2222220012Sarwer et al[@bib31]2122222013Layus et al[@bib33]2222220012Sarwer et al[@bib16]2122222013Efthymiou et al[@bib34]2222222014Kun et al[@bib32]2212222013Groutz et al[@bib18]2222222014Aleid et al[@bib19]2222220012[∗](#tbl2fnlowast){ref-type="table-fn"}Reis et al[@bib28]Jadad scale: 3/5[∗](#tbl2fnlowast){ref-type="table-fn"}Janik et al[@bib17]AHRQ scale: 9/11[^4][^5]

Meta-analysis results {#sec4}
=====================

Primary Outcomes {#sec4.1}
----------------

### IIEF {#sec4.1.1}

A total of 10 studies reported the IIEF score. We analyzed the IIEF-Total Score and its 5 domains separately to obtain a comprehensive understanding of the effect of bariatric surgery on erectile function in men.

### IIEF-Total Score {#sec4.1.2}

Six studies[@bib17], [@bib19], [@bib27], [@bib29], [@bib30], [@bib33] reported the total score of the IIEF before and after surgery (75 points in total), and the meta-analysis results of the fixed-effect model showed that postoperative male erectile function was significantly improved compared with that before surgery (MD = 8.2; 95% CI = 5.52−10.88; *P* \< .00001). For I^2^ = 9%, no significant heterogeneity was found ([Figure 2.1](#fig2){ref-type="fig"}).Figure 2.1Forest plot-comparison of preoperative and postoperative International Index of Erectile Function-Total Score.

### IIEF-Erectile Function {#sec4.1.3}

Six self-controlled prospective cohort studies[@bib16], [@bib18], [@bib27], [@bib30], [@bib31], [@bib34] and 1 cross-sectional study[@bib17] reported the erectile function score of the patients. The meta-analysis results of the fixed-effect model showed that the erectile function score of the patients at 1 year after bariatric surgery was significantly higher than that before surgery, and the erectile function was significantly improved (MD = 3.76; 95% CI = 2.34−5.19; *P* \< .00001). For I^2^ = 0, no significant heterogeneity was found ([Figure 2.2](#fig3){ref-type="fig"}).Figure 2.2Forest plot-comparison of preoperative and postoperative International Index of Erectile Function score.

### IIEF-Desire and IIEF-Orgasm Function {#sec4.1.4}

Seven studies[@bib16], [@bib17], [@bib18], [@bib27], [@bib30], [@bib31], [@bib34] reported preoperative and postoperative IIEF-Desire scores and IIEF-Orgasm Function scores in morbidly obese patients, with a total of 269 participants. The results of meta-analysis of fixed-effect model showed that the desire score of the patients after weight loss surgery was significantly higher 1 year after surgery than that before surgery (MD = 0.93; 95% CI = 0.55−1.32; *P* \< .00001; [Figure 2.3](#fig4){ref-type="fig"}), and the orgasm function score was not significantly improved compared with that before surgery (MD = 0.26; 95% CI = -0.15 to 0.68; *P* = .21). For I^2^ \<50%, no significant heterogeneity was found ([Figure 2.4](#fig5){ref-type="fig"}).Figure 2.3Forest plot-comparison of preoperative and postoperative International Index of Erectile Function-Desire.Figure 2.4Forest plot-comparison of preoperative and postoperative International Index of Erectile Function-Orgasm Function.

### IIEF-Intercourse Satisfaction and IIEF-Total Satisfaction {#sec4.1.5}

7 studies[@bib16], [@bib17], [@bib18], [@bib27], [@bib30], [@bib31], [@bib34] reported preoperative and postoperative sexual satisfaction scores and total satisfaction scores in morbidly obese patients, with a total of 269 participants. The results of the meta-analysis of the random-effects model showed that patients' intercourse satisfaction (MD = 1.73; 95% CI = 0.43−3.03; *P* \< .01; [Figure 2.5](#fig6){ref-type="fig"}) and total satisfaction (MD = 1.28; 95% CI = 0.56−2.00; *P* = .0005; [Figure 2.6](#fig7){ref-type="fig"}) after bariatric surgery were significantly higher than before surgery. The I^2^ was 59% and 65%, respectively, indicating the presence of heterogeneity.Figure 2.5Forest plot-comparison of preoperative and postoperative International Index of Erectile Function-Intercourse Satisfaction.Figure 2.6Forest plot-comparison of preoperative and postoperative International Index of Erectile Function-Total Satisfaction.

### Five-Item IIEF {#sec4.1.6}

3 studies[@bib28], [@bib32], [@bib33] reported IIEF-5, including 87 participants. The meta-analysis of fixed-effect model showed that the erectile function of morbidly obese patients after bariatric surgery was significantly improved (MD = 5.45; 95% CI = 3.38−7.52; *P* \< .00001). For I^2^ = 0, no significant heterogeneity was found ([Figure 2.7](#fig8){ref-type="fig"}).Figure 2.7Forest plot-comparison of preoperative and postoperative Five-Item International Index of Erectile Function.

Secondary Outcomes {#sec4.2}
------------------

### BMI {#sec4.2.1}

In the literature we included, a total of 7 studies[@bib17], [@bib18], [@bib19], [@bib28], [@bib29], [@bib30], [@bib32] gave explicit BMI changes. The random-effect model analysis showed that bariatric surgery could significantly reduce the BMI of patients (MD = -13.73; 95% CI = -17.23 to -10.22; *P* \< .00001). I^2^ = 88%, indicating significant heterogeneity ([Figure 3.1](#fig9){ref-type="fig"}).Figure 3.1Forest plot-comparison of preoperative and postoperative body mass index.

### Total Testosterone and Free Testosterone {#sec4.2.2}

To explore the changes in hormone levels before and after weight loss surgery was not our main purpose, so it was not searched as part of the retrieval strategy. Therefore, only 4 literatures[@bib16], [@bib28], [@bib30], [@bib32] included in our study contained the data of changes in testosterone before and after surgery. The random-effect model analysis showed that bariatric surgery could significantly increase the level of total testosterone (MD = 7.49; 95% CI = 3.56−11.42; *P* = 0.0002; [Figure 3.2](#fig10){ref-type="fig"}) and free testosterone (MD = 0.1; 95% CI = 0.07−0.13; *P* \< .0001; [Figure 3.3](#fig11){ref-type="fig"}). I^2^ was 92% and 0%, respectively, indicating significant heterogeneity only in the total testosterone outcome indicator group.Figure 3.2Forest plot-comparison of preoperative and postoperative Total Testosterone.Figure 3.3Forest plot-comparison of preoperative and postoperative Free Testosterone.

### Subgroup Analysis {#sec4.2.3}

In addition to 1 cross-sectional study and 1 RCT, the studies we included were mainly prospective, cross-sectional, cohort studies. In order to verify whether different study types and comparisons would not produce significant bias in results, we conducted subgroup analysis on the study types and comparisons, and the results showed that the significance of major outcome indicators did not change. Nearly half of the included studies (5/12) had undergone \>1 type of bariatric surgery, and no single result of specific bariatric surgery was reported. Gastric bypass was adopted as the surgical approach in all 6 studies. Therefore, we absolutely conducted a subgroup analysis of gastric-bypass (GB) alone, and the results showed that the significance of the other major outcome indicators remained unchanged except for the change of IIEF-Intercourse Satisfaction to no significant improvement (MD = 0.88; 95% CI = -0.69 to 2.45; *P* = .27; [Table 3](#tbl3){ref-type="table"}).Table 3Subgroup analysis of study types, control methods, and operation methodSubgroup analysisIIEF-Total \[95% CI\]IIEF-Erectile Function \[95% CI\]IIEF-Sexual Desire \[95% CI\]IIEF-Orgasm Function \[95% CI\]IIEF-Intercourse Satisfaction \[95% CI\]IIEF-Total Satisfaction \[95% CI\]ComparisonBefore vs after8.10 \[5.38, 10.82\]3.94 \[2.39, 5.49\]0.90 \[0.49, 1.31\]0.33 \[-0.13, 0.79\]2.23 \[0.85, 3.62\]1.35 \[0.50, 2.20\]Study typeProspective cohort8.10 \[5.38, 10.82\]3.66 \[2.20, 5.11\]0.84 \[0.44, 1.24\]0.40 \[-0.05, 0.85\]1.78 \[0.34, 3.22\]1.31 \[0.51, 2.10\]Operation methodGastric-bypass6.66 \[3.37, 9.96\]3.16 \[1.04, 5.28\]0.79 \[0.02, 1.55\]0.40 \[-0.22, 1.02\]0.88 \[-0.69, 2.45\]0.90 \[0.24, 1.57\][^6]

### Sensitivity Analysis {#sec4.2.4}

There was moderate heterogeneity in the analysis of IIEF-Intercourse Satisfaction and IIEF-Total Satisfaction, 59% and 65%, respectively. To find the source of the heterogeneity, we removed each study in turn and found that when we removed Efthymiou et al,[@bib34] I^2^ became 0 ([Table 4](#tbl4){ref-type="table"}). This indicates that the source of heterogeneity in the two meta-analyses was Efthymiou et al.[@bib34] We also used the Stata software to get the forest plots after removing each study in turn ([Figure 4](#fig12){ref-type="fig"}). When we removed Efthymiou et al,[@bib34] we found that the result changed (from MD = 1.73; 95% CI = 0.43−3.03; *P* \< .01 to MD = 1.28; 95% CI = 0.5−2.05; *P* = .001) in the IIEF-Intercourse Satisfaction outcome group and in the IIEF-Total Satisfaction outcome group, the result changed (from MD = 1.28; 95% CI = 0.56−2.00; *P* = .0005 to MD = 0.93; 95% CI = 0.47−1.38; *P* \< .0001). In terms of data changes before and after the removal of Efthymiou et al,[@bib34] despite the heterogeneity, the final conclusions were not affected.Table 4Sensitivity analysisStudy omittedHeterogeneity (A)Heterogeneity (B)I^2^*P* valueI^2^*P* valueAraújo et al[@bib27]71%.0464%.004Sarwer et al[@bib31]57%.000865%.0007Mora et al[@bib30]70%.0264%.002Sarwer et al[@bib16]71%.00464%.001Efthymiou et al[@bib34]0%.0010%\< .0001Janik et al[@bib17]71%.0265%.001Groutz et al[@bib18]71%.0465%.004[^7][^8]Figure 4Forest plots for sensitivity analysis. BMI = body mass index; IIEF, International Index of Erectile Function.

There was high heterogeneity in the analysis of BMI and total testosterone, I^2^ = 88% and 92%, respectively. We removed each study in turn and observed heterogeneity changes and found that all I^2^ values were \>80%. At the same time, the forest plots obtained by using Stata software also showed that the results obtained after removal of each study all deviated from the median line to a certain extent ([Figure 4](#fig12){ref-type="fig"}). By switching the random-effect model to the fixed-effect model, we found that the result changed (from MD = -13.73; 95% CI = -17.23 to -10.22; *P* \< .00001 to MD = -12.38; 95% CI = -13.53 to -11.23; *P* \< .00001) in the BMI outcome group and in the total testosterone outcome group, the result changed (from MD = 7.49; 95% CI = 3.56−11.42; *P* = .0002 to MD = 5.54; 95% CI = 4.56−6.52; *P* \< .0001). The difference before and after switching was relatively small, and the conclusion was not changed, indicating that although heterogeneity existed, there was no obvious influence on the final results, and our results were relatively robust.

### Publication Bias {#sec4.2.5}

We quantified publication bias by the Egger method and found that all *P* values of outcome indicator groups were \>0.05, suggesting no significant publication bias ([Figure 5](#fig13){ref-type="fig"}).Figure 5Publication bias - Egger graphs. BMI = body mass index; IIEF, International Index of Erectile Function.

Discussion {#sec5}
==========

As far as we know, our study is the latest and most comprehensive meta-analysis on the effect of bariatric surgery on sexual function in morbidly obese patients. Current studies have shown that weight loss surgery can significantly improve men's erectile function, but the current study sample size is small, and there is still a lack of large RCTs. Therefore, our meta-analysis integrated the data of all 420 participants and refined to every part of erectile function, and obtained results with strong demonstration effect, providing a strong basis for clinical decisions.

The results of our meta-analysis showed that the erectile function, sexual desire, and sexual satisfaction of obese patients after bariatric surgery were significantly improved, but there was no significant difference in the orgasmic function before and after surgery. Dallal et al[@bib35] evaluated 97 male patients using Brief Sexual Function Inventory score as the evaluation index of sexual function. The results showed that the average postoperative erectile function score was 2.5 points higher than that before the operation, and the average sexual desire score was 1.4 points higher than that before the operation. The results were consistent with the results of our meta-analysis. Because testosterone levels and BMI changes were not used as retrieval indicators, they were used as secondary outcome indicators in our study. The results of our meta-analysis showed that weight loss surgery could significantly reduce the BMI of patients, and the levels of total testosterone and free testosterone were also significantly increased. A previous meta-analysis on changes in hormone levels after weight loss surgery also reached the same conclusion as ours.[@bib36] Based on a careful study of the data, we found that the higher the initial value of BMI, the greater the decrease in BMI, and the changes in testosterone level were observed. We speculated that this trend might also occur in the 5 domains of IIEF. However, there are only 3 studies[@bib17], [@bib18], [@bib30] that contain both BMI reduction data and IIEF 5 domains data, and only 2 studies[@bib16], [@bib30] that contain both hormone level changes and IIEF 5 domains data, so we can only guess the general trend and cannot get specific links through subgroup analysis and other methods. More large RCTs are needed to confirm this hypothesis.

The reasons for the significant improvement in erectile function, sexual desire, and sexual satisfaction may be related to the correction of postoperative vascular endothelial dysfunction and hormone imbalance in obese patients and the cure or improvement of obesity-related comorbidities.[@bib37], [@bib38], [@bib39] Obesity is thought to be a state of chronic oxidative stress and chronic inflammation, both of which interact in a vicious cycle.[@bib40] In obese patients, the production of a large amount of reactive oxygen species and the decline in the body\'s antioxidant capacity, as well as the decrease in blood flow and abnormal platelet agglutination in the body cause endothelial dysfunction, thereby causing erectile dysfunction.[@bib41] Weight loss improves endothelial function by increasing endothelium-dependent vasodilation, endothelial activation markers, and decreasing proinflammatory cytokine levels and insulin resistance.[@bib39], [@bib42], [@bib43] In terms of sex hormones, sexual desire and erectile function are significantly correlated with sex hormone balance, and androgens are indispensable in promoting male erectile function and maintaining sexual desire.[@bib44] The blocking of androgen can induce apoptosis of smooth muscle cells and increase of collagen.[@bib45] Rapid weight loss after bariatric surgery can increase androgen levels and improve endothelial function in obese patients.[@bib39] In addition to erectile dysfunction, diseases associated with obesity, such as diabetes, coronary heart disease, hypertension, and depression, can be controlled and alleviated to a certain extent.[@bib46] Lifestyle interventions can also reduce weight, but they are less effective than bariatric surgery.[@bib47] According to Sarwer et al,[@bib31] weight loss caused by lifestyle intervention can also improve sexual function, and there was no significant difference in the 5 structural domains of IIEF. There are still few studies comparing lifestyle intervention to bariatric surgery for sexual function improvement and further studies are needed.

According to the results of the subgroup analysis, we excluded the possible bias caused by different study types and control types, determined the stability of the results, and determined the effect of using only GB surgical method. Currently, there are 4 kinds of bariatric surgery, including GB, sleeve gastrectomy, and biliopancreatic diversion and gastric banding.[@bib48] It is worth noting that the improvement of sexual function in the 5 domains by only using the GB surgical method is lower than the overall result, which may indicate that the effect of the GB surgical method is inferior to other surgical methods. However, to our confusion, studies have shown that GB is not only as effective as or even better than other surgical methods in reducing weight and alleviating obesity-related complications, but also has a higher success rate.[@bib46], [@bib48], [@bib49] Due to the inadequacy of our data and the potential impact of ethnicity and initial BMI on outcomes, large RCTs are needed to further validate the effect of different surgical procedures on sexual function and its 5 domains.

We analyzed differences between heterogeneity sources and other studies to explore why these studies are sources of heterogeneity. Considering that the judgment of satisfaction was subjective, it may be related to the difference in the definition of "satisfaction" between the Greek population and other groups. By analyzing data from each study, we found that compared with patients with a lower baseline BMI, those with a higher baseline had a greater decrease in BMI and a greater increase in testosterone, which we speculated might be a source of heterogeneity.

Limitations {#sec5.1}
-----------

It is undeniable that this study also has several limitations. First, only 1 RCT was included, and the rest were observational studies. Second, although we had 420 participants, the sample size of a single study was small. Large RCTs are still needed. Third, although we discussed the effect of bariatric surgery on BMI and hormone levels, due to limited data, we were unable to further explore the specific impact of BMI changes and hormone levels on the 5 IIEF domains. Fourth, most of the follow-up time was about 1 year, lacking long-term efficacy indicators.

Conclusion {#sec6}
==========

In conclusion, bariatric surgery could improve the erectile function, sexual desire, sexual intercourse satisfaction, and total satisfaction in morbidly obese men. Due to limited data on BMI and hormone levels, our meta-analysis had some limitations. More clinical studies are needed to further explore the relationship between bariatric surgery and male sexual function.
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===========================

All relevant data are within the paper and its Supporting Information files

Jiangnan Xu and Qian Wu contributed equally to this study.

*Conflicts of Interest:* The authors report not conflicts of interest.

*Funding:* None.

[^1]: A = BMI change; B = IIEF-Total; C = IIEF-Erectile Function; D = IIEF-Sexual Desire; E = IIEF-Orgasm Function; F = IIEF-Intercourse Satisfaction; G = IIEF-Total Satisfaction; H = IIEF-5; I = Total testosterone; J = Free testosterone.

[^2]: BMI = body mass index; BPD = biliary pancreatic diversion; CS = cannot say; IIEF = International Index of Erectile Function; IIEF-5 = 5-item International Index of Erectile Function; LGB = laparoscopic gastric-bypass; LM = lifestyle modiﬁcation; LSG = laparoscopic sleeve gastrectomy; MT = multidisciplinary team; NIP = nonintensive program; PC = prospective cohort; RC = retrospective cohort RCT = randomized clinical trial; RY = Roux-en-Y; RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy.

[^3]: CS = cross-sectional study.

[^4]: AHRQ = Agency for Healthcare Research and Quality.

[^5]: We used Jadad and AHRQ scales to evaluate Reis et al[@bib28]and Janik et al,[@bib17] respectively, and found that both of them had relatively high quality.

[^6]: IIEF = International Index of Erectile Function.

[^7]: A. IIEF-Contact Satisfaction. B. IIEF-Total Satisfaction.

[^8]: IIEF = International Index of Erectile Function.
